{{Rsnum
|rsid=305061
|Chromosome=16
|position=85942053
|Orientation=plus
|GMAF=0.2346
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 48.7 | 44.2
| HCB | 0.0 | 27.7 | 72.3
| JPT | 2.7 | 22.1 | 75.2
| YRI | 0.7 | 25.2 | 74.1
| ASW | 1.8 | 31.6 | 66.7
| CHB | 0.0 | 27.7 | 72.3
| CHD | 0.9 | 27.5 | 71.6
| GIH | 10.9 | 31.7 | 57.4
| LWK | 2.7 | 24.5 | 72.7
| MEX | 1.7 | 32.8 | 65.5
| MKK | 5.1 | 37.2 | 57.7
| TSI | 12.7 | 52.0 | 35.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20062064
|Trait=Chronic lymphocytic leukemia
|Title=Common variants at 2q37.3, 8q24.21, 15q21.3 abd 16q24.1 influence chronic lymphocytic leukemia risk
|RiskAllele=T
|Pval=4E-7
|OR=1.22
|ORtxt=[1.12-1.32]
}}

{{PMID Auto
|PMID=20855867
|Title=Inherited genetic susceptibility to monoclonal B-cell lymphocytosis
}}

{{PMID Auto GWAS
|PMID=22700719
|Trait=None
|Title=Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia.
|RiskAllele=
|Pval=9E-8
|OR=1.3300
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}